ClinicalTrials.gg

Program

VV119

A development code. Also written as “VV119 (in healthy adult subjects)”, “VV119(in adult patients with schizophrenia)” and “VV119(SAD)”.

Its studies are mostly in Schizophrenia, led by Vigonvita Life Sciences.

Furthest: phase 2, since Jul 6, 20264 company-led studies, 4 open or runningNext primary completion: Oct 31, 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Vigonvita Life Sciences44 open or runningphase 2since Jul 6, 2026Oct 17, 2023Oct 31, 2027phase 2 · NCT07703956

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 17, 2023First study: phase 1 study in SchizophreniaFirst studyNCT06105151 · 82 enrolled · China
  2. Jul 2, 2024Phase 1 study in SchizophreniaNCT06504290 · 40 planned · China
  3. Nov 16, 2025Phase 1 study in Healthy VolunteersNCT07240636 · 16 planned · China
  4. Jul 6, 2026Phase 2 study in SchizophreniaPhase 2 reachedNCT07703956 · 500 planned · China

Ahead

  1. Oct 31, 2027Primary completion: phase 2 study in SchizophreniaNCT07703956

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07703956Schizophrenia · China2Not yet recruitingOct 31, 2027500
NCT07240636Healthy Volunteers · China1RecruitingOct 202616
NCT06504290Schizophrenia · China1RecruitingOct 1, 202640
NCT06105151Schizophrenia · China1Active, not recruitingOct 202682

How it is read

Names in the registry

  • “VV119”, 2 entries
  • “VV119 (in healthy adult subjects)”, 1 entry
  • “VV119(in adult patients with schizophrenia)”, 1 entry
  • “VV119(SAD)”, 1 entry
  • “VV119(FE)”, 1 entry

Codes read as this program: VV119.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.